Intellectual Property Rights — Revision Notes

⚡ 30-Second Revision

IPR protects creations of mind: Patents, Copyrights, Trademarks, GIs, Designs, PPV&FR.
Patents Act 1970 (amended 2005): 20-year product patents.
Section 3(d) Patents Act: Prevents evergreening (Novartis case).
Compulsory Licensing (Sec 84, 92): Public health safeguard (Natco-Bayer).
Copyright Act 1957: Author's life + 60 years.
Trade Marks Act 1999: Renewable indefinitely.
GI Act 1999: Protects origin-linked products (Darjeeling Tea, Basmati).
PPV&FR Act 2001: Balances breeders' and farmers' rights.
TRIPS Agreement (WTO): Mandated IPR minimum standards.
Biopiracy: Unauthorized use of traditional knowledge (Neem, Turmeric).
TKDL: India's defensive mechanism against biopiracy.
National IPR Policy 2016: 'Creative India; Innovative India' vision.

2-Minute Revision

1
TRIPS Agreement Impact — The WTO's TRIPS Agreement obliged India to shift from a process-patent-only regime to product patents across all technologies, including pharmaceuticals, by 2005. This led to significant amendments in the Patents Act, 1970. However, India strategically utilized TRIPS flexibilities, such as Section 3(d) to curb evergreening and compulsory licensing provisions, to balance patent protection with public health needs and access to affordable medicines. The Doha Declaration further affirmed these flexibilities.
2
Biopiracy — This refers to the unethical and unauthorized appropriation of traditional knowledge and biological resources, often from indigenous communities, for commercial gain without fair compensation. India has been a victim of biopiracy, with notable cases involving Basmati rice, Turmeric, and Neem. These incidents highlighted the urgent need for robust protection mechanisms for traditional knowledge.
3
Traditional Knowledge Protection — India has developed pioneering mechanisms to protect its vast traditional knowledge base. The Traditional Knowledge Digital Library (TKDL) is a crucial defensive tool, documenting traditional knowledge in various international languages to serve as 'prior art' and prevent erroneous patent grants globally. Additionally, the Biological Diversity Act, 2002, mandates prior informed consent and equitable benefit-sharing for the use of biological resources and associated knowledge, further safeguarding community rights.
4
Compulsory Licensing — A key flexibility under the Patents Act, 1970 (Sections 84 and 92) and permitted by the TRIPS Agreement, compulsory licensing allows the government to authorize a third party to manufacture and sell a patented product without the patent holder's consent. This is typically invoked under specific conditions like public health emergencies, non-availability, or unaffordability of the patented product, ensuring access to essential goods, as exemplified by the Natco-Bayer Nexavar case.

5-Minute Revision

Comprehensive IPR Framework for UPSC

India's Intellectual Property Rights (IPR) framework is a complex yet crucial area for UPSC. It encompasses various types of rights, each governed by specific legislation, and is deeply influenced by international agreements.

At its core, IPR aims to incentivize innovation and creativity while simultaneously addressing public interest concerns like access to essential medicines and protection of traditional knowledge. The constitutional basis lies in Article 19(1)(g) and 19(6), balancing individual rights with reasonable restrictions for public welfare.

Key statutes include the Patents Act, 1970 (for inventions), Copyright Act, 1957 (for artistic/literary works), Trade Marks Act, 1999 (for brand identity), Designs Act, 2000 (for aesthetics), Geographical Indications Act, 1999 (for origin-linked products), and the unique PPV&FR Act, 2001 (for plant varieties and farmers' rights).

The TRIPS Agreement, a WTO mandate, significantly shaped India's modern IPR laws, compelling a shift to product patents. However, India has strategically utilized TRIPS flexibilities, notably Section 3(d) to prevent 'evergreening' and compulsory licensing provisions, to maintain a balance between innovator rights and public access, especially in the pharmaceutical sector.

Biopiracy, the unauthorized commercial exploitation of traditional knowledge, remains a significant concern, addressed by initiatives like the Traditional Knowledge Digital Library (TKDL) and the Biological Diversity Act, 2002, which mandates benefit-sharing.

The National IPR Policy 2016 provides a holistic vision for fostering a 'Creative India; Innovative India,' emphasizing awareness, generation, legal framework, administration, commercialization, enforcement, and human capital development.

Understanding this multi-layered framework, its historical evolution, and its contemporary challenges is essential for UPSC aspirants.

Exam-Relevant Case Studies Review

Case studies are vital for illustrating the practical application and implications of IPR laws. The Novartis AG v. Union of India (2013) case is paramount, as it upheld Section 3(d) of the Patents Act, preventing 'evergreening' and reinforcing India's commitment to public health over extended patent monopolies.

The Natco Pharma Ltd. v. Bayer Corporation (2012) case marked India's first compulsory license, demonstrating the government's willingness to use TRIPS flexibilities to ensure access to affordable essential medicines.

In the realm of traditional knowledge, the Basmati Rice (RiceTec), Turmeric, and Neem patent cases are classic examples of biopiracy and India's successful challenges, highlighting the importance of 'prior art' and the TKDL.

These cases underscore the tension between global IPR norms and national developmental priorities, providing concrete examples for Mains answers on India's balanced IPR approach, public health, and traditional knowledge protection.

For Prelims, knowing the parties, the IPR type involved, and the core issue of each case is crucial. For Mains, analyzing the broader policy implications and India's strategic response is key.

Prelims Revision Notes

1
IPR Types & Acts — Patents (Patents Act 1970), Copyrights (Copyright Act 1957), Trademarks (Trade Marks Act 1999), Designs (Designs Act 2000), Geographical Indications (GI Act 1999), Plant Variety Protection (PPV&FR Act 2001). Know the specific act for each.
2
Patent Duration — 20 years from filing date. Copyright: Author's life + 60 years. Design: 10 years, extendable by 5. Trademark/GI: Renewable indefinitely.
3
Patents Act Key Sections — Section 3(d) (prevents evergreening, requires enhanced efficacy), Sections 84 & 92 (compulsory licensing conditions). Remember the Novartis (Glivec) case for 3(d) and Natco-Bayer (Nexavar) for compulsory licensing.
4
TRIPS Agreement — Administered by WTO. Mandated product patents post-2005. Doha Declaration reaffirmed public health flexibilities.
5
Biopiracy — Unauthorized use of traditional knowledge. Examples: Basmati, Turmeric, Neem cases. Know the core issue for each.
6
Traditional Knowledge Protection — TKDL (Traditional Knowledge Digital Library) as 'prior art' database. Biological Diversity Act 2002 (prior informed consent, benefit-sharing).
7
PPV&FR Act 2001 — Unique for protecting both plant breeders' rights and farmers' rights (to save, use, sell seeds).
8
National IPR Policy 2016 — Vision 'Creative India; Innovative India'. Seven objectives (awareness, generation, legal, admin, commercialization, enforcement, human capital).
9
Distinctions — Trademark vs. GI (source vs. origin). Patent vs. Copyright (idea/function vs. expression).

Mains Revision Notes

1
India's Balanced IPR Approach — Thesis: India strategically balances international obligations (TRIPS) with domestic public interest (access, traditional knowledge). Argument points: Pre-TRIPS stance, post-TRIPS amendments, strategic use of flexibilities (Sec 3(d), compulsory licensing), TKDL, PPV&FR Act, National IPR Policy 2016. Use case studies (Novartis, Natco, Basmati) as evidence.
2
TRIPS Flexibilities — Focus on Section 3(d) (evergreening, Novartis case) and Compulsory Licensing (public health, Natco case). Explain their rationale, legal basis, and impact on pharmaceutical access. Connect to Doha Declaration.
3
Biopiracy & Traditional Knowledge — Define biopiracy, provide Indian examples (Neem, Turmeric, Basmati). Explain defensive mechanisms: TKDL (prior art), Biological Diversity Act (PIC, benefit-sharing), GI Act. Discuss ethical dimensions of exploitation.
4
Ethical Issues in Biotech/Pharma Patenting — Discuss the 'innovation vs. access' dilemma. Ethical concerns: patenting life forms/genes, high drug prices. India's response: Section 3(d), compulsory licensing, Section 3(j) exclusions. Connect to bioethics principles.
5
National IPR Policy 2016 — Analyze its seven objectives. Assess its effectiveness in fostering innovation, streamlining administration, and strengthening enforcement. Discuss challenges in implementation and future outlook.
6
Inter-sectoral Linkages — Connect IPR to economic growth, international trade, public health, social justice, environment, and science & technology policy. Use Vyyuha Connect points.

Vyyuha Quick Recall

Vyyuha Quick Recall: TRIPS-B-C-D for IPR Essentials!

T - TRIPS Agreement: WTO's IPR standards, led to 2005 Patent Act changes. R - Rights Types: Patents, Copyrights, Trademarks, GIs, Designs, PPV&FR. I - India's Balance: Innovation vs. Access (Sec 3(d), Compulsory Licensing). P - Patents Act 1970: Core law, 20-year term, Sec 3(d) & Compulsory Licensing. S - Strategic Cases: Novartis (3d), Natco (CL), Basmati/Neem/Turmeric (Biopiracy).

B - Biopiracy: Unauthorized use of Traditional Knowledge (TK). C - Constitutional Basis: Article 19(1)(g) & 19(6) for reasonable restrictions. D - Doha Declaration: Reaffirmed TRIPS flexibilities for public health.